U.S. market Closed. Opens in 7 hours 43 minutes

VECT | VectivBio Holding AG Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
Revenue27.34MN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A
Gross Profit27.34MN/AN/AN/A
Operating Expenses107.86M86.72M57.26M24.32M
Selling, General & Admin33.91M35.81M14.02M8.23M
Research & Development73.95M50.18M43.03M15.98M
Other Operating ExpensesN/A729.00K207.00K102.00K
Operating Income-80.52M-86.72M-57.26M-24.32M
Other Expenses / Income-13.10M-229.00K-2.68M834.00K
Before Tax Income-93.63M-86.94M-59.94M-23.48M
Income Tax Expenses107.00K64.00K554.00K50.00K
Net Income-93.73M-87.01M-60.50M-23.53M
Interest Expenses3.16M36.00K554.00K50.00K
Basic Shares Outstanding44.13M26.96M9.60M23.35M
Diluted Shares Outstanding44.13M26.96M9.60M23.35M
EBITDA-79.85M-86.41M-57.55M-24.15M
EBITDA Margin-292.04%0.00%0.00%0.00%
EBIT-90.46M-86.91M-59.39M-23.43M
EBIT Margin-330.87%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙